Probing the role of Coniferin and Tetrahydrocurcumin from Traditional Chinese medicine against PSAT1 in early-stage ovarian cancer: An in silico study.
Ovarian cancer, a formidable gynaecological malignancy, poses a significant global health challenge, and it is characterised by late-stage diagnosis and a high mortality rate. Even in its early stages, when treatment choices are scarce, ovarian cancer is still a complicated cancer to treat. In this...
Saved in:
Main Authors: | Jia Zhang, Shalesh Gangwar, Nagmi Bano, Shaban Ahmad, Mohammed S Alqahtani, Khalid Raza |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2025-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0313585 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Brokering responsible research and innovation in in silico medicine
by: Elisa Elhadj, et al.
Published: (2024-12-01) -
Application of lipidomics in the study of traditional Chinese medicine
by: Yang Yang, et al.
Published: (2025-02-01) -
Tailoring traditional Chinese medicine in cancer therapy
by: Shuiquan Li, et al.
Published: (2025-01-01) -
Medicinal Effect, In Silico Bioactivity Prediction, and Pharmaceutical Formulation of Ageratum conyzoides L.: A Review
by: Jasvidianto C. Kotta, et al.
Published: (2020-01-01) -
Traditional ayurvedic medicine as a therapeutic option in oral cancer: An alternative medicine perspective
by: Kshirod Kumar Ratha, et al.
Published: (2024-03-01)